Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Clinical trial NCT01714817 · TERMINATED
Trial details
- NCT number
- NCT01714817
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-22
- Primary completion
- 2016-11-21
- Enrollment
- 695
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.